Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program.
about
Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseasesMicroRNA as Type I Interferon-Regulated Transcripts and Modulators of the Innate Immune ResponseFcγ receptors and ligands and cardiovascular diseaseImmune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodiesFcγ Receptors in Solid Organ TransplantationControl of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunityA type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosisAim2 deficiency in mice suppresses the expression of the inhibitory Fcgamma receptor (FcgammaRIIB) through the induction of the IFN-inducible p202, a lupus susceptibility proteinImmune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodesDengue virus compartmentalization during antibody-enhanced infection.FcγRIIB and autoimmunity.Plasmacytoid dendritic cells, interferon signaling, and FcγR contribute to pathogenesis and therapeutic response in childhood immune thrombocytopenia.Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in mice.Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice.Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor.In vitro blood cell responsiveness to IFN-α predicts clinical response independently of IL28B in hepatitis C virus genotype 1 infected patients.DNA methylation dynamics during ex vivo differentiation and maturation of human dendritic cells.Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes.Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity.Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammationCell type and gender-dependent differential regulation of the p202 and Aim2 proteins: implications for the regulation of innate immune responses in SLE.Role of chaperones and FcgammaR in immunogenic death.DNA-responsive inflammasomes and their regulators in autoimmunityRituximab inhibits Kv1.3 channels in human B lymphoma cells via activation of FcγRIIB receptorsViral Manipulation of Host Inhibitory Receptor Signaling for Immune Evasion.Interferon-inducible Ifi200-family genes as modifiers of lupus susceptibility.Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy.Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancerDendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myelomaInteractions of tumor cells with dendritic cells: balancing immunity and toleranceInterferon-inducible Ifi200-family genes in systemic lupus erythematosusTargeting of the immune system in systemic lupus erythematosus.Monoclonal antibodies for cancer immunotherapy.A signal-switch hypothesis for cross-regulation of cytokine and TLR signalling pathways.Antitumor activities of agonistic anti-TNFR antibodies require differential FcγRIIB coengagement in vivo.Cross-regulation of signaling by ITAM-associated receptors.LILR-B1 blocks activating FcγR signaling to allow antibody dependent enhancement of dengue virus infection.Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue.B cells as therapeutic targets in SLE.Regulation of autoreactive B cell responses to endogenous TLR ligands.
P2860
Q26783175-42ECCDD4-8FCB-4AED-9327-CD1CEBD6EFEEQ26798503-E4554ECB-4917-4CEF-8902-309EB35D9C22Q27021449-B0EAD47A-2750-4E69-BA69-32E8DA087AA0Q28069362-B1799094-4A76-44B2-876C-E5D29ED4A1F4Q28076012-74586F11-6875-4691-B178-DF04DFD715E6Q28085328-26692C7A-D646-4B24-BAEC-A4DE29B89575Q28257957-55220826-813E-46A0-B957-08AB95AB29F8Q30426448-888EABF7-5EB1-4923-952B-DD4D585CF654Q30612568-AEF8F848-6843-4268-A51E-4469B79C0BF2Q30834861-8F7240C8-7CBF-4AF6-AEF6-BAFA43D88106Q30981881-4C27DE72-1DA7-4772-9B9D-D596FE23CB7AQ33409032-CBFB3639-0E51-4CED-93D0-1F6174281C6EQ33409413-69253534-53CE-4905-BE0A-0634E3B69C36Q33584637-359FC4BE-E550-4B6D-B608-DC349A938442Q33737913-9E0AA43D-51A2-4B7A-8EB1-2F3833B39ED5Q33958609-FC34BE4F-BAF8-44F1-BA38-6F4F0B3360B3Q34090282-F221FFEB-3153-4B31-A4DB-5E34CA3EA6C9Q34550268-5C366E3A-BB05-44BE-A410-335B26B814CDQ35064255-8662D528-32CF-474B-9A2E-BC3F0E4C9BD5Q35103549-FF1A6CC6-A497-4E67-8BB4-120D3C661E48Q35536260-EA884F3B-7D72-49EA-BB97-B911CD6FC174Q35575030-2C78A158-024D-4050-B87A-4417CFF1E3F5Q35785671-8FD5E635-2514-4A88-BB88-9C1DCAF5736EQ36102906-2480EFC3-18F3-4CC3-A12E-A999F68E81C9Q36120111-A451C5B9-05F7-40B7-8DC2-D4B29119F217Q36183169-7FB28215-E0FF-44EA-894B-F3C4DC0B016CQ36628520-182BAC50-EEF9-47A8-A2D5-2DDF8BE1AC43Q36835186-8729E4BA-17E1-478E-A518-E472A1260D95Q36915925-2B58393D-363C-4951-B5E9-213CE4042E04Q36975749-A9F86D16-DFB7-4570-B1C5-3026929FE260Q36979779-BB72A118-EAAC-4BF0-8C71-B733F500CE1EQ37060593-855E073F-BB08-4298-86D1-75ABE4BABE90Q37181031-4593E1E8-B208-48E8-A609-4AC2EDC24898Q37267214-9A6738C4-7166-48BE-880F-988812E1F2F3Q37353182-257AB743-4733-434C-A26D-55F3996F3356Q37366524-9717164B-6473-4027-B311-31CAD992C47CQ37599853-D743375F-EFD8-40DD-951A-3D3BC933813EQ37599913-3DA4EBD9-4CD8-4220-AF7A-AC74DD6E6376Q37603296-0199CA4E-6246-4B55-8A5C-24DEB6AF8D22Q37656307-1412A30E-9349-4BC1-83EA-C2B5A0B0CB6D
P2860
Selective blockade of the inhibitory Fcgamma receptor (FcgammaRIIB) in human dendritic cells and monocytes induces a type I interferon response program.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Selective blockade of the inhi ...... I interferon response program.
@ast
Selective blockade of the inhi ...... I interferon response program.
@en
type
label
Selective blockade of the inhi ...... I interferon response program.
@ast
Selective blockade of the inhi ...... I interferon response program.
@en
prefLabel
Selective blockade of the inhi ...... I interferon response program.
@ast
Selective blockade of the inhi ...... I interferon response program.
@en
P2093
P2860
P356
P1476
Selective blockade of the inhi ...... I interferon response program.
@en
P2093
Anjli Kukreja
Devi Banerjee
Elyana Matayeva
Jeffrey V Ravetch
John Connolly
Kavita M Dhodapkar
Madhav V Dhodapkar
Maria Concetta Veri
Ralph M Steinman
P2860
P304
P356
10.1084/JEM.20062545
P407
P577
2007-05-14T00:00:00Z